Literatur

1.Brown J Jr, Folk JC, Reddy CV, Kimura AE (1996) Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome.

Ophthalmology 103: 1100–1105

32. Olk RJ, Burgess DB, McCormick PA (1984) Subfoveal and juxtafoveal subretinal neovascularization in the presu-

med ocular histoplasmosis syndrome. Visual prognosis. Ophthalmology 91: 1592–1602

3.Saxe SJ, Grossniklaus HE, Lopez PF, Lambert HM, Sternberg P Jr, L‘Hernault N (1993) Ultrastructural features of surgically excised subretinal neovascular membranes in the ocular histoplasmosis syndrome. Arch Ophthalmol

111:88–95

4.O‘Toole L, Tufail A, Pavesio C (2005) Management of choroidal neovascularization in uveitis. Int Ophthalmol Clin

45:157–177

5.Flaxel CJ, Owens SL, Mulholland B, Schwartz SD, Gregor ZJ (1998) The use of corticosteroids for choroidal neovascularisation in young patients. Eye 12: 266–272

6.Dees C, Arnold JJ, Forrester JV, Dick AD (1998) Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis. Arch Ophthalmol 116: 1456–1461

7.Rechtman E, Allen VD, Danis RP, Pratt LM, Harris A, Speicher MA (2003) Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome. Am J Ophthalmol 136: 739–741

8.Macular Photocoagulation Study Group (1994) Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Arch Ophthalmol 112: 500–509

9.Macular Photocoagulation Study Group (1989) Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Arch Ophthalmol 107: 344–352

10.Hawkins BS, Bressler NM, Bressler SB et al. (2004) Surgical removal vs. observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9. Arch Ophthalmol 122: 1597–1611

11.Hawkins BS, Miskala PH, Bass EB et al. (2004) Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST Report No. 10. Arch Ophthalmol 122: 1616–1628

12.Spaide RF, Freund KB, Slakter J, Sorenson J, Yannuzzi LA, Fisher Y (2002) Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy. Retina 22: 545– 549

13.Leslie T, Lois N, Christopoulou D, Olson JA, Forrester JV (2005) Photodynamic therapy for inflammatory choroidal

neovascularisation unresponsive to immunosuppression. Br J Ophthalmol 89: 147–150

14.Busquets MA, Shah GK, Wickens J et al. (2003) Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome. Retina 23: 299–306

15.Liu JC, Boldt HC, Folk JC, Gehrs KM (2004) Photodynamic therapy of subfoveal and juxtafoveal choroidal neovascularization in ocular histoplasmosis syndrome: a retrospective case series. Retina 24: 863–867

16.Shah GK, Blinder KJ, Hariprasad SM et al. (2005) Photodynamic therapy for juxtafoveal choroidal neovascularization due to ocular histoplasmosis syndrome. Retina 25: 26–32

17.Chatterjee S, Gibson JM (2003) Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy. Br J Ophthalmol 87: 925–927

18.Ruiz-Moreno JM, Montero JA, Arias L et al. (2006) Photodynamic therapy in subfoveal and juxtafoveal idiopathic and postinflammatory choroidal neovascularization. Acta Ophthalmol Scand 84: 743–748

19.Rogers AH, Duker JS, Nichols N, Baker BJ (2003) Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology 110: 1315–1320

20.Wachtlin J, Heimann H, Behme T, Foerster MH (2003) Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases. Graefes Arch Clin Exp Ophthalmol 241: 899–906

21.Gerth C, Spital G, Lommatzsch A, Heiligenhaus A, Pauleikhoff D (2006) Photodynamic therapy for choroidal neovascularization in patients with multifocal choroiditis and panuveitis. Eur J Ophthalmol 16: 111–118

22.Lipski A, Bornfeld N, Jurklies B (2008) Photodynamic therapy with verteporfin in pediatric and young adult patients: long-term treatment results of choroidal neovascularisations. Br J Ophthalmol 92: 655–660

23.Mauget-Faysse M, Mimoun G, Ruiz-Moreno JM et al. (2006) Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis. Retina 26: 396–403

24.Parodi MB, Iacono P, Spasse S, Ravalico G (2006) Photodynamic therapy for juxtafoveal choroidal neovascularization associated with multifocal choroiditis. Am J Ophthalmol 141: 123–128

25.Postelmans L, Pasteels B, Coquelet P et al. (2005) Photodynamic therapy for subfoveal classic choroidal neovascularization related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like). Ocul Immunol Inflamm 13: 361–366

26.Nowilaty SR, Bouhaimed M (2006) Photodynamic therapy for subfoveal choroidal neovascularisation in Vogt-Koya- nagi-Harada disease. Br J Ophthalmol 90: 982–986

27.Rosenfeld PJ, Saperstein DA, Bressler NM et al. (2004) Photodynamic therapy with verteporfin in ocular histo-